NCT00043043View on ClinicalTrials.gov

Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2003

Study Completion Date

October 31, 2007

Conditions
Colorectal Cancer
Interventions
DRUG

celecoxib

Trial Locations (2)

20889-5600

National Naval Medical Center, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00043043 - Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia | Biotech Hunter | Biotech Hunter